# Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study

> **NCT02145169** · NA · COMPLETED · sponsor: **Albert Einstein Healthcare Network** · enrollment: 20 (actual)

## Conditions studied

- Emergence Reaction
- Procedural Sedation

## Interventions

- **DRUG:** Inhaled Nitrous Oxide

## Key facts

- **NCT ID:** NCT02145169
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145169, "Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02145169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*